| Product Code: ETC12463419 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Imatinib Drug Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Imatinib Drug Market - Industry Life Cycle |
3.4 Angola Imatinib Drug Market - Porter's Five Forces |
3.5 Angola Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Angola Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Angola Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Angola Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Angola Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Angola Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Angola |
4.2.2 Growing awareness and diagnosis of chronic myeloid leukemia (CML) in the country |
4.2.3 Government initiatives to improve healthcare infrastructure and access to essential medicines |
4.3 Market Restraints |
4.3.1 High cost of imatinib drug leading to affordability issues for patients |
4.3.2 Limited availability of specialized healthcare facilities for cancer treatment in Angola |
5 Angola Imatinib Drug Market Trends |
6 Angola Imatinib Drug Market, By Types |
6.1 Angola Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Angola Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Angola Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Angola Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Angola Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Angola Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Angola Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Angola Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Angola Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Angola Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Angola Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Angola Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Angola Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Angola Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Angola Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Angola Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Angola Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Angola Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Angola Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Angola Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Angola Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Angola Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Angola Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Angola Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Angola Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Angola Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Angola Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Angola Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Angola Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Angola Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Angola Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Angola Imatinib Drug Market Import-Export Trade Statistics |
7.1 Angola Imatinib Drug Market Export to Major Countries |
7.2 Angola Imatinib Drug Market Imports from Major Countries |
8 Angola Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Number of healthcare professionals trained in managing CML |
8.3 Rate of government investment in healthcare infrastructure for cancer treatment |
9 Angola Imatinib Drug Market - Opportunity Assessment |
9.1 Angola Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Angola Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Angola Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Angola Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Angola Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Angola Imatinib Drug Market - Competitive Landscape |
10.1 Angola Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Angola Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here